You are here

Naureen Starling, BSc(Hons), MBBS, MRCP, MD(Res)

Department of Medical Oncology, The Royal Marsden Hospital, London, UK

Naureen Starling is Consultant Medical Oncologist at The Royal Marsden Hospital, London, UK, specializing in the treatment of gastrointestinal (GI) cancers, and a Senior Lecturer (honorary faculty) within the Division of Clinical Studies at the Institute of Cancer Research (ICR), London. She graduated from University College London with First Class Honours in physiology (BSc) and distinctions in clinical pharmacology/therapeutics and pathology. She undertook general medical training at University College Hospital and Northwick Park/St Mark’s Hospitals, all in London, and specialist training in medical oncology at The Royal Marsden Hospital. Her postgraduate degree at the ICR focused on the genomics and therapeutics of oesophageal cancer.  

Her research interests in gastrointestinal cancers (oesophageal, gastric, pancreatic, neuroendocrine, and colorectal) are focussed on earlier-phase clinical trials, novel therapeutics, and the delivery of individualized medicine to patients with GI cancers. Dr Starling is the Principal Investigator on numerous international clinical trials of novel drugs in oesophago-gastric, pancreatic, and colorectal cancer and a member several multicentre clinical trial steering and safety review committees. 

Dr Starling is Associate Director of Clinical Research at the Royal Marsden Hospital, the Clinical Lead for the Royal Marsden’s West Wing Clinical Research Centre, and the Upper GI Lead for the South London Cancer Research Network, and she serves on the UK National Cancer Research Institute oesophago-gastric subgroup and on the National Institute of Clinical Excellence (NICE) Oesophago-gastric Cancer Guideline Committee. Dr Starling also holds educational roles including the NIHR Training Lead for the RM/ICR National Institute of Health Research (NIHR) Biomedical Research Centre and Deputy Training Program Director (one of three) for South London Medial Oncology Training.


Search this site

Search form

ECCO2017 symposium webcast: Treatment evolution in advanced GI malignancies

Welcome and introduction - Florian Lordick

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Featured Content

New Book Content


This online Resource Centre has been sponsored by Lilly Oncology

Note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subject to an independent editorial review.

Share